S SCIENCE COMPANY, LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22 JPY | 0.00% |
|
0.00% | +4.76% |
Valuation
| Fiscal Period: March | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 4,325 | 5,187 | 3,540 |
| Enterprise Value (EV) 1 | 3,360 | 3,448 | 2,233 |
| P/E ratio | -16.1 x | -13.5 x | -33.7 x |
| Yield | - | - | - |
| Capitalization / Revenue | 4 x | 4.49 x | 2.6 x |
| EV / Revenue | 3.11 x | 2.99 x | 1.64 x |
| EV / EBITDA | -14.7 x | -13.8 x | -19.2 x |
| EV / FCF | - | -9,433,907 x | -19,063,310 x |
| FCF Yield | - | -0% | -0% |
| Price to Book | 2.41 x | 1.95 x | 1.35 x |
| Nbr of stocks (in thousands) | 100,592 | 140,192 | 141,592 |
| Reference price 2 | 43.00 | 37.00 | 25.00 |
| Announcement Date | 6/28/21 | 6/30/22 | 6/30/23 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net sales 1 | 1,081 | 1,155 | 1,360 |
| EBITDA 1 | -229 | -249 | -116 |
| EBIT 1 | -240 | -260 | -117 |
| Operating Margin | -22.2% | -22.51% | -8.6% |
| Earnings before Tax (EBT) 1 | -264 | -323 | -97 |
| Net income 1 | -269 | -329 | -105 |
| Net margin | -24.88% | -28.48% | -7.72% |
| EPS 2 | -2.674 | -2.740 | -0.7416 |
| Free Cash Flow | - | -365.5 | -117.1 |
| FCF margin | - | -31.65% | -8.61% |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 6/28/21 | 6/30/22 | 6/30/23 |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2021 S1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2024 Q1 | 2024 S1 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 521 | 451 | 300 | 340 | 659 | 304 | 446 | 936 | 339 |
| EBITDA | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -133 | -130 | -99 | -34 | -46 | -37 | -59 | -85 | -90 |
| Operating Margin | -25.53% | -28.82% | -33% | -10% | -6.98% | -12.17% | -13.23% | -9.08% | -26.55% |
| Earnings before Tax (EBT) 1 | -107 | -122 | -90 | -30 | -37 | -28 | 216 | 382 | 147 |
| Net income 1 | -110 | -124 | -93 | -31 | -40 | -30 | 213 | 379 | 147 |
| Net margin | -21.11% | -27.49% | -31% | -9.12% | -6.07% | -9.87% | 47.76% | 40.49% | 43.36% |
| EPS 2 | -1.100 | -1.160 | -0.7400 | -0.2200 | -0.2900 | -0.2100 | 1.510 | 2.680 | 1.040 |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/13/20 | 11/11/21 | 2/9/22 | 8/10/22 | 11/10/22 | 2/13/23 | 8/10/23 | 11/10/23 | 2/13/24 |
1JPY in Million2JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net Debt 1 | - | - | - |
| Net Cash position 1 | 965 | 1,739 | 1,307 |
| Leverage (Debt/EBITDA) | - | - | - |
| Free Cash Flow | - | -366 | -117 |
| ROE (net income / shareholders' equity) | - | -14.7% | -3.95% |
| ROA (Net income/ Total Assets) | - | -6.56% | -2.48% |
| Assets 1 | - | 5,015 | 4,227 |
| Book Value Per Share 2 | 17.90 | 19.00 | 18.60 |
| Cash Flow per Share 2 | 8.000 | 12.30 | 9.200 |
| Capex | - | 239 | 1 |
| Capex / Sales | - | 20.69% | 0.07% |
| Announcement Date | 6/28/21 | 6/30/22 | 6/30/23 |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +4.76% | 20.25M | |
| +73.30% | 25.38B | |
| +0.82% | 1.27B | |
| +26.76% | 1.16B | |
| -5.05% | 1.06B | |
| +2.48% | 267M | |
| +28.99% | 127M | |
| 0.00% | 76.02M | |
| +95.80% | 71.25M |
- Stock Market
- Equities
- 5721 Stock
- Financials S Science Company, Ltd.
